New pill aims to curb heavy drinking: phase 2 trial results expected
NCT ID NCT06545916
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase 2 trial tested whether the drug sunobinop (V117957) can reduce heavy drinking in adults with moderate to severe alcohol use disorder who want treatment. 209 participants took either sunobinop or a placebo daily for several weeks. The study measured changes in heavy drinking days and total drinks consumed.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
sunobinop (V117957)
What this could lead to
If successful, this could lead to a new medication that helps people with alcohol use disorder drink less heavily.
What could go wrong
This is a phase 2 trial, so it is still early. The drug may not work better than a placebo, and side effects are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Belmont Medical Office
Brooklyn, New York, 11212, United States
-
Bio Terra Med SRL
Bucharest, 010701, Romania
-
Cabinet Medical Individual Dr. Andreea Popa
Bucharest, 050802, Romania
-
Cebis Usa, Llc
Houston, Texas, 77074, United States
-
Inquest Clinical Research
Baytown, Texas, 77521, United States
-
Ohio Clinical Trials
Columbus, Ohio, 43212, United States
-
Spitalul Universitar De Urgenta Militar Central "Dr. Carol Davila"
Bucharest, 010825, Romania